1. Spinal and bulbar muscular atrophy Clinical trials / Disease details

Clinical trials : 18 / Drugs : 15 - (DrugBank : 8) / Drug target genes : 10 - Drug target pathways : 17

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05517603 (ClinicalTrials.gov)	February 28, 2023	23/8/2022	A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201In Patients ...	A Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, First-In-Patient Study Of AJ201To Evalua ...	Spinal and Bulbar Muscular Atrophy;Kennedy's Disease	Drug: AJ201;Drug: Placebo	AnnJi Pharmaceutical Co., Ltd.	NULL	Recruiting	18 Years	N/A	Male	24	Phase 1/Phase 2	United States

First Previous1Next Last